4C Biomed

4C Biomed combines cutting-edge science, real-world clinical insights and unique autologous cell systems to drive the research and development of immuno-oncology therapies.

Health Tech & Life Sciences
Active
Seed Netanya, Israel Founded 2016
Last updated 2026-07-26
Total raised
Last: Undisclosed Round 2023-01
Stage
Seed
Founded
2016
Headcount
5
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences

About

4C Biomed is a biomed R&D startup in the field of Immuno-Oncology. The company develops a uniquely sensitive immunological-based screening platform designed to fight cancer and auto-immune disorders. Their platform develops innovative treatments for bladder cancer and offers immuno-oncology and auto-immunity novel therapeutic antibodies, enabling physicians to access new drug candidates that identify targets and develop potent drugs to control the patient's immune system to fight cancer efficiently. Their lead drug is an IND-ready asset and is planned to enter clinical Phase I in 2026.

Funding history · 1 round · — total

2022-12
Undisclosed Round Undisclosed
★ Israel Biotech Fund

Headcount over time

From 10 (2024-03) to 11 (2025-12) · +1 (+10%) · 4 points · source: Finder history + radar grounding
110 2024-03 2025-12

Q&A

What is 4C Biomed's primary focus?
4C Biomed is a biomed R&D startup in the field of Immuno-Oncology, developing an immunological-based screening platform to fight cancer and auto-immune disorders.
When was 4C Biomed founded?
4C Biomed was founded in February 2016.
What is the total amount of funding 4C Biomed has raised to date?
4C Biomed has raised a total of $9,500,000 USD.
When did 4C Biomed complete its most recent funding round?
4C Biomed completed a Seed funding round in January 2023.
What is the status of 4C Biomed's lead drug candidate?
4C Biomed's lead drug is an IND-ready asset and is planned to enter clinical Phase I in 2026.
Where is 4C Biomed headquartered?
4C Biomed is headquartered in Netanya, Israel.
Who are the co-founders of 4C Biomed?
The co-founders of 4C Biomed are Eyal Greenberg, Gal Markel, Jacob Schachter, and Anthony Angel.

Team · 4

Eyal Greenberg
Founder · Co-founder & CEO
Gal Markel
Founder · Co-founder & CSO
Jacob Schachter
Founder · CMO & Co-Founder
Anthony Angel
Founder · Co-Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

cancer-therapyoncologyimmunotherapyimmunologydrug-discoverycancerdrug-developmentpharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Website4cbiomed.com/
LinkedInlinkedin.com/company/28145356

Identifiers & details

Founded2016-2
Employees (exact)5
OfficesLondon

Radar intelligence

Patents

EPO4

Web history (Wayback)

Domain4cbiomed.com

Certificate / subdomain footprint

Subdomains3

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515406163
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2016-02-21
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events0
Registered addressהמלאכה 5 נתניה